Phio Pharmaceuticals Files 8-K
Ticker: PHIO · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1533040
| Field | Detail |
|---|---|
| Company | Phio Pharmaceuticals Corp. (PHIO) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Phio Pharma filed an 8-K on April 9, 2025, likely with financial updates and other key events.
AI Summary
On April 9, 2025, Phio Pharmaceuticals Corp. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant business occurrences. No specific financial figures or new events were detailed in the provided excerpt.
Why It Matters
This filing signals that Phio Pharmaceuticals Corp. is making material disclosures to the SEC, which could impact investors' understanding of the company's current status and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard disclosure document (8-K) and the provided excerpt does not contain specific negative or positive material information.
Key Players & Entities
- Phio Pharmaceuticals Corp. (company) — Registrant
- April 9, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Marlborough, Massachusetts (location) — Principal executive offices
- RXi Pharmaceuticals Corp (company) — Former company name
FAQ
What specific "Other Events" are being reported by Phio Pharmaceuticals Corp. on April 9, 2025?
The provided excerpt of the 8-K filing does not detail the specific "Other Events" being reported.
What is the significance of filing under "Financial Statements and Exhibits"?
This indicates that the company is providing updated financial information or submitting relevant exhibits, which could include financial reports or other supporting documents.
When was Phio Pharmaceuticals Corp. previously known as RXi Pharmaceuticals Corp?
The date of the name change from RXi Pharmaceuticals Corp. to Phio Pharmaceuticals Corp. was October 19, 2011.
What is the principal business address of Phio Pharmaceuticals Corp.?
The principal executive offices are located at 11 Apex Drive, Suite 300A, PMB 2006, Marlborough, Massachusetts 01752.
What is the SIC code for Phio Pharmaceuticals Corp.?
The Standard Industrial Classification (SIC) code for Phio Pharmaceuticals Corp. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 regarding Phio Pharmaceuticals Corp. (PHIO).